Page last updated: 2024-10-25

debrisoquin and Adenocarcinoma

debrisoquin has been researched along with Adenocarcinoma in 3 studies

Debrisoquin: An adrenergic neuron-blocking drug similar in effects to GUANETHIDINE. It is also noteworthy in being a substrate for a polymorphic cytochrome P-450 enzyme. Persons with certain isoforms of this enzyme are unable to properly metabolize this and many other clinically important drugs. They are commonly referred to as having a debrisoquin 4-hydroxylase polymorphism.

Adenocarcinoma: A malignant epithelial tumor with a glandular organization.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sugimura, H1
Caporaso, NE2
Shaw, GL1
Modali, RV1
Gonzalez, FJ1
Hoover, RN2
Resau, JH1
Trump, BF1
Weston, A1
Harris, CC1
Speirs, CJ1
Murray, S1
Davies, DS1
Biola Mabadeje, AF1
Boobis, AR1
Tucker, MA1
Hayes, RB1
Pickle, LW1
Issaq, HJ1
Muschik, GM1
Green-Gallo, L1
Buivys, D1
Aisner, S1

Other Studies

3 other studies available for debrisoquin and Adenocarcinoma

ArticleYear
Human debrisoquine hydroxylase gene polymorphisms in cancer patients and controls.
    Carcinogenesis, 1990, Volume: 11, Issue:9

    Topics: Adenocarcinoma; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cytochrome P-450 CYP2D6; Cytochrome

1990
Debrisoquine oxidation phenotype and susceptibility to lung cancer.
    British journal of clinical pharmacology, 1990, Volume: 29, Issue:1

    Topics: Adenocarcinoma; Aged; Aged, 80 and over; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Debrisoqui

1990
Lung cancer and the debrisoquine metabolic phenotype.
    Journal of the National Cancer Institute, 1990, Aug-01, Volume: 82, Issue:15

    Topics: Adenocarcinoma; Case-Control Studies; Debrisoquin; Female; Humans; Isoquinolines; Lung Diseases, Obs

1990